- Location
Actavis
"-
Philips Utilizes Another Top Medtech Talent
Apr 7, 2015Posted in Medical Device Business by Chris Newmarker on April 3, 2015 Robert Cascella was previously CEO of Hologic. He joins Philips as the Dutch multinational increasingly focuses on what it calls HealthTech. Robert Cascella, who ...
Tags: Philips, LED components, Medicine
-
Allergan Fought off Hostile Takeover Attempt by Valeant Pharmaceuticals for Past 8 Months
Dec 17, 2014Posted in Medical Device Business by Nancy Crotti on December 15, 2014 Just when you thought they couldn’t get more widespread or expensive, the medical device mergers-and-acquisitions of 2014 continue to astound. Allergan ...
Tags: DNA sequencing market, lab products, Health
-
Five Companies with The Most Stock Price Growth Over 2014
Dec 15, 2014Posted in Medical Device Business by Chris Newmarker on December 11, 2014 2014 has turned out to be a pretty decent year for the world’s 40 largest medical device companies: Only six of them have seen their stock prices decline, and ...
Tags: Medical Device, Health
-
The Deal Helped Propel The Dow and S&P 500 to Record Highs on November 8
Nov 19, 2014Posted in Medical Device Business by Brian Buntz on November 18, 2014 Irvine, CA–based Allergan has been adamant in fighting off a hostile takeover attempt from Valeant Pharmaceuticals International for the past seven months. But ...
Tags: silicone breast, Botox, Health
-
Actavis Plc Has Received Approval From The U.S. FDA on ANDA
Jan 10, 2014Actavis plc (NYSE: ACT) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Telmisartan Immediate-Release Tablets, 20 mg, 40 mg and 80 mg, a ...
-
Actavis PLC Would Prevent Actavis From Commercializing Its Anda Product Prior
Dec 30, 2013Actavis plc (NYSE: ACT) today confirmed that its subsidiary, Warner Chilcott Company LLC, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Ethinyl Estradiol and ...
Tags: Actavis, Warner Chilcott Company LLC, Abbreviated New Drug Application
-
Warner Chilcott Has Filed an ANDA with The U.S. FDA Seeking Approval
Dec 30, 2013Today confirmed that its subsidiary, Warner Chilcott Company LLC, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Ethinyl Estradiol and Etonogestrel Vaginal ...
-
Horizon Pharma and SkyePharma Have Filed a Patent Infringement Lawsuit
Aug 30, 2013Horizon Pharma and SkyePharma have filed a patent infringement lawsuit against Watson Laboratories (WLF) and certain related companies like Actavis Pharma, Andrx and Actavis Inc. The lawsuit was filed in the US District Court for the ...
Tags: Horizon Pharma
-
Actavis Has Purchased Worldwide Rights for Palau Pharma's Albaconazole Antifungal Agent
Aug 9, 2013Actavis Specialty Brands has purchased worldwide rights for Palau Pharma's Albaconazole antifungal agent indicated for the treatment of vulvo-vaginal candidiasis, onychomycosis and other antifungal applications. Possessing a ...
-
Actavis Rolled out New Formulations of Fioricet and Fioricet with Codeine
Aug 2, 2013US generics drug maker Actavis has rolled out new formulations of Fioricet (butalbital, acetaminophen and caffeine capsules, USP) and Fioricet with Codeine (butalbital, acetaminophen, caffeine and codeine phosphate, USP). Both medicines ...
-
Mylan Pharmaceuticals Has Introduced Norethindrone for The Prevention of Pregnancy in US
Jul 18, 2013Mylan Pharmaceuticals has introduced Norethindrone Tablets USP, 0.35mg, which is the generic version of Watson Laboratories' (now Actavis) Nor-Q.D. tablets, 0.35mg for 28-day cycle, for the prevention of pregnancy in the US. The ...
Tags: Generic Contraceptive Pill, Mylan
-
The USFDA Has Cleared Actavis's ANDA for Lamotrigine Orally Disintegrating Tablets
Jul 17, 2013The USFDA has cleared Actavis' abbreviated new drug application (ANDA) for Lamotrigine orally disintegrating tablets, 25mg, 50mg, 100mg and 200mg. A generic version of GlaxoSmithKline's Lamictal ODT, the antiepileptic drug is indicated ...
-
Actavis Has Won FDA Approval for Abbreviated New Drug Application
Jul 16, 2013Specialty pharmaceutical company Actavis has won FDA approval for abbreviated new drug application (ANDA) of generic equivalent to Endo Health Solutions' Opana ER. Oxymorphone Hydrochloride extended-release tablets, which is available in ...
Tags: FDA, ANDA, Generic Opana ER
-
Teva Pharmaceutical Industries Has Introduced Generic Version
Jun 25, 2013Teva Pharmaceutical Industries has introduced generic version of Pfizer's Viagra (sildenafil) in Germany, UK, Italy, the Netherlands, Switzerland, Ireland, Austria, Belgium and Denmark following patent expiry. Offered through the ...
Tags: Pfizer's Viagra, Viagra
-
Actavis Has Acquired Worldwide Rights for Valeant's Metronidazole 1.3% Gel Antibiotic
May 7, 2013Actavis Specialty Brands has acquired worldwide rights for Valeant's Metronidazole 1.3% vaginal gel antibiotic development product for approximately $55m. Metronidazole 1.3% vaginal gel antibiotic development product is a topical ...
Tags: Actavis, Metronidazole, Gel Antibiotic
